首页> 外文期刊>Expert opinion on pharmacotherapy >Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.
【24h】

Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.

机译:新兴和艺术血凝素靶向流感病毒抑制剂的状态。

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Seasonal influenza vaccination, together with FDA-approved neuraminidase (NA) and polymerase acidic (PA) inhibitors, is the most effective way for prophylaxis and treatment of influenza infections. However, the low efficacy of prevailing vaccines to newly emerging influenza strains and increasing resistance to available drugs drives intense research to explore more effective inhibitors. Hemagglutinin (HA), one of the major surface proteins of influenza strains, represents an attractive therapeutic target to develop such new inhibitors.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号